TY - JOUR
T1 - Utility of the Modified Isolated-check Visual Evoked Potential Technique in Functional Glaucoma Assessment
AU - Kolomeyer, Natasha N.
AU - Drinkwater, Owen J.
AU - Drivas, Eleni
AU - Zakik, Amir
AU - Zemon, Vance
AU - Sidoti, Paul A.
AU - Tsai, James C.
AU - Panarelli, Joseph F.
N1 - Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Precis:Cortical response to low-contrast stimuli, as measured by isolated-check visual evoked potential (icVEP) technology, has the potential to provide functional assessment that may complement standard achromatic perimetry in assessing glaucomatous change.Purpose:To evaluate the utility of modified icVEP testing in detecting functional glaucomatous damage.Materials and Methods:Subjects who met predetermined criteria of controls, glaucoma suspects, preperimetric glaucoma, or glaucoma were enrolled in this prospective cross-sectional study from a single tertiary care center. Glaucoma patients were further categorized as early, moderate, advanced, or severe on the basis of Hodapp-Anderson-Parrish criteria. icVEP testing was performed with ten 2-second runs per qualified eye using the EvokeDx testing software. Multivariate statistics were used to calculate signal-to-noise ratios (SNR) and perform outlier analysis.Results:In total, 140 eyes met criteria (mean±SD; age of 63±14 y; 49% male; logMAR visual acuity, 0.11±0.089). There was no significant difference in age, sex, or logMAR visual acuity among the groups. Controls had a significantly higher SNR than all other groups (P<0.003), including patients with preperimetric glaucoma. Among those with glaucoma, the early glaucoma patients had significantly higher SNR than the moderate, advanced, or severe glaucoma cohorts (P<0.04). The optimal SNR cutoff for differentiating between glaucomatous and nonglaucomatous eyes was 0.95, both with (sensitivity 82%, specificity 76%) and without (sensitivity 82%, specificity 100%) glaucoma suspects included in analysis.Conclusions:icVEP technology has the potential to complement standard achromatic perimetry in functional assessment of glaucomatous defects.
AB - Precis:Cortical response to low-contrast stimuli, as measured by isolated-check visual evoked potential (icVEP) technology, has the potential to provide functional assessment that may complement standard achromatic perimetry in assessing glaucomatous change.Purpose:To evaluate the utility of modified icVEP testing in detecting functional glaucomatous damage.Materials and Methods:Subjects who met predetermined criteria of controls, glaucoma suspects, preperimetric glaucoma, or glaucoma were enrolled in this prospective cross-sectional study from a single tertiary care center. Glaucoma patients were further categorized as early, moderate, advanced, or severe on the basis of Hodapp-Anderson-Parrish criteria. icVEP testing was performed with ten 2-second runs per qualified eye using the EvokeDx testing software. Multivariate statistics were used to calculate signal-to-noise ratios (SNR) and perform outlier analysis.Results:In total, 140 eyes met criteria (mean±SD; age of 63±14 y; 49% male; logMAR visual acuity, 0.11±0.089). There was no significant difference in age, sex, or logMAR visual acuity among the groups. Controls had a significantly higher SNR than all other groups (P<0.003), including patients with preperimetric glaucoma. Among those with glaucoma, the early glaucoma patients had significantly higher SNR than the moderate, advanced, or severe glaucoma cohorts (P<0.04). The optimal SNR cutoff for differentiating between glaucomatous and nonglaucomatous eyes was 0.95, both with (sensitivity 82%, specificity 76%) and without (sensitivity 82%, specificity 100%) glaucoma suspects included in analysis.Conclusions:icVEP technology has the potential to complement standard achromatic perimetry in functional assessment of glaucomatous defects.
KW - electrophysiology
KW - glaucoma
KW - glaucomatous optic neuropathy
KW - visual evoked potential
UR - http://www.scopus.com/inward/record.url?scp=85077861506&partnerID=8YFLogxK
U2 - 10.1097/IJG.0000000000001439
DO - 10.1097/IJG.0000000000001439
M3 - Article
C2 - 31917721
AN - SCOPUS:85077861506
SN - 1057-0829
VL - 29
SP - 258
EP - 263
JO - Journal of Glaucoma
JF - Journal of Glaucoma
IS - 4
ER -